| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |